Richelle Candice Charles, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Typhoid Fever | 23 | 2024 | 195 | 5.840 |
Why?
|
Cholera | 44 | 2024 | 747 | 5.140 |
Why?
|
Antibodies, Bacterial | 46 | 2024 | 1468 | 4.630 |
Why?
|
Salmonella typhi | 20 | 2024 | 199 | 3.770 |
Why?
|
Vibrio cholerae O1 | 26 | 2024 | 243 | 3.740 |
Why?
|
O Antigens | 23 | 2024 | 196 | 3.160 |
Why?
|
Cholera Vaccines | 22 | 2024 | 262 | 2.810 |
Why?
|
Immunoglobulin A | 35 | 2024 | 979 | 2.500 |
Why?
|
Vibrio cholerae | 14 | 2023 | 793 | 1.790 |
Why?
|
Antigens, Bacterial | 10 | 2024 | 1155 | 1.520 |
Why?
|
Bangladesh | 36 | 2023 | 728 | 1.500 |
Why?
|
Immunoglobulin M | 25 | 2024 | 1529 | 1.360 |
Why?
|
Antibodies, Viral | 20 | 2023 | 3142 | 1.240 |
Why?
|
Paratyphoid Fever | 6 | 2022 | 34 | 1.210 |
Why?
|
Immunoglobulin G | 38 | 2024 | 4540 | 1.180 |
Why?
|
Vibrio cholerae O139 | 5 | 2023 | 54 | 1.050 |
Why?
|
Vaccines, Conjugate | 12 | 2024 | 328 | 0.870 |
Why?
|
Carrier State | 5 | 2024 | 525 | 0.780 |
Why?
|
Immunologic Memory | 13 | 2022 | 1353 | 0.770 |
Why?
|
Salmonella enterica | 2 | 2024 | 75 | 0.770 |
Why?
|
Bartonella henselae | 1 | 2021 | 15 | 0.770 |
Why?
|
Cat-Scratch Disease | 1 | 2021 | 23 | 0.760 |
Why?
|
Salmonella paratyphi A | 7 | 2024 | 47 | 0.760 |
Why?
|
Serologic Tests | 2 | 2020 | 383 | 0.740 |
Why?
|
Immunity, Mucosal | 4 | 2020 | 481 | 0.730 |
Why?
|
Immunoassay | 3 | 2024 | 746 | 0.730 |
Why?
|
Dysentery, Bacillary | 3 | 2024 | 74 | 0.660 |
Why?
|
Vaccination | 17 | 2024 | 3356 | 0.650 |
Why?
|
Magnetite Nanoparticles | 2 | 2017 | 315 | 0.610 |
Why?
|
Antibody Specificity | 1 | 2019 | 1060 | 0.560 |
Why?
|
Bacteremia | 7 | 2015 | 980 | 0.560 |
Why?
|
Immunity, Humoral | 5 | 2020 | 604 | 0.550 |
Why?
|
DNA Probes | 1 | 2016 | 543 | 0.510 |
Why?
|
Point-of-Care Systems | 2 | 2024 | 1201 | 0.510 |
Why?
|
Cholera Toxin | 12 | 2024 | 559 | 0.480 |
Why?
|
Shigella Vaccines | 2 | 2024 | 10 | 0.460 |
Why?
|
Antibodies, Neutralizing | 7 | 2022 | 1931 | 0.450 |
Why?
|
Salmonella | 4 | 2023 | 126 | 0.430 |
Why?
|
Antibody Formation | 8 | 2024 | 1400 | 0.420 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3076 | 0.420 |
Why?
|
Biliary Tract | 1 | 2013 | 135 | 0.420 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3196 | 0.410 |
Why?
|
Lipopolysaccharides | 11 | 2024 | 2204 | 0.390 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 611 | 0.380 |
Why?
|
B-Lymphocytes | 11 | 2022 | 4738 | 0.360 |
Why?
|
Vaccines, Inactivated | 8 | 2023 | 179 | 0.340 |
Why?
|
Mucous Membrane | 3 | 2019 | 656 | 0.340 |
Why?
|
Sensitivity and Specificity | 11 | 2024 | 14641 | 0.340 |
Why?
|
Haiti | 9 | 2023 | 549 | 0.340 |
Why?
|
Typhoid-Paratyphoid Vaccines | 2 | 2020 | 39 | 0.330 |
Why?
|
Lymphocytes | 3 | 2022 | 2610 | 0.330 |
Why?
|
Bacterial Proteins | 5 | 2014 | 3824 | 0.330 |
Why?
|
Lymph Nodes | 1 | 2021 | 3485 | 0.330 |
Why?
|
Shigella flexneri | 3 | 2024 | 119 | 0.330 |
Why?
|
Antibodies, Monoclonal | 3 | 2021 | 9160 | 0.320 |
Why?
|
Disease Outbreaks | 6 | 2018 | 1755 | 0.320 |
Why?
|
Child, Preschool | 29 | 2024 | 42058 | 0.310 |
Why?
|
Cross Reactions | 5 | 2022 | 818 | 0.310 |
Why?
|
Interferon-gamma | 2 | 2014 | 3156 | 0.300 |
Why?
|
Host-Pathogen Interactions | 2 | 2014 | 1444 | 0.300 |
Why?
|
Antibody-Producing Cells | 5 | 2021 | 140 | 0.300 |
Why?
|
Salmonella typhimurium | 1 | 2009 | 344 | 0.280 |
Why?
|
Leukocytes, Mononuclear | 4 | 2017 | 1826 | 0.280 |
Why?
|
Clinical Laboratory Techniques | 3 | 2020 | 748 | 0.270 |
Why?
|
Neuraminidase | 3 | 2022 | 199 | 0.270 |
Why?
|
Humans | 104 | 2024 | 758381 | 0.260 |
Why?
|
Child | 35 | 2024 | 79813 | 0.260 |
Why?
|
Adult | 52 | 2024 | 219916 | 0.250 |
Why?
|
Shigella sonnei | 1 | 2024 | 7 | 0.240 |
Why?
|
Young Adult | 29 | 2024 | 58808 | 0.240 |
Why?
|
Seroepidemiologic Studies | 5 | 2024 | 394 | 0.240 |
Why?
|
Vaccines, Combined | 2 | 2021 | 70 | 0.230 |
Why?
|
Adolescent | 31 | 2024 | 87888 | 0.230 |
Why?
|
Proteome | 1 | 2013 | 1855 | 0.220 |
Why?
|
Endemic Diseases | 1 | 2024 | 190 | 0.220 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2009 | 1130 | 0.220 |
Why?
|
Shigella | 1 | 2023 | 69 | 0.210 |
Why?
|
Communicable Diseases | 2 | 2024 | 877 | 0.200 |
Why?
|
Cytokines | 4 | 2020 | 7338 | 0.200 |
Why?
|
Urine | 2 | 2021 | 363 | 0.200 |
Why?
|
Cholecystectomy | 1 | 2024 | 406 | 0.200 |
Why?
|
Blood Group Antigens | 1 | 2023 | 187 | 0.200 |
Why?
|
Proteomics | 4 | 2022 | 3816 | 0.200 |
Why?
|
Administration, Oral | 10 | 2021 | 3993 | 0.190 |
Why?
|
Zingiberales | 1 | 2000 | 1 | 0.190 |
Why?
|
Guaiacol | 1 | 2000 | 5 | 0.190 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3801 | 0.190 |
Why?
|
Agglutination | 1 | 2020 | 41 | 0.190 |
Why?
|
Flank Pain | 1 | 2021 | 43 | 0.190 |
Why?
|
Polymerase Chain Reaction | 3 | 2021 | 6068 | 0.190 |
Why?
|
Animals, Suckling | 1 | 2020 | 69 | 0.190 |
Why?
|
Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.180 |
Why?
|
Tetanus Toxin | 2 | 2023 | 46 | 0.180 |
Why?
|
Sanitation | 2 | 2011 | 85 | 0.180 |
Why?
|
Female | 53 | 2024 | 390316 | 0.180 |
Why?
|
Chromatography, Affinity | 3 | 2024 | 534 | 0.180 |
Why?
|
Nucleocapsid Proteins | 1 | 2020 | 76 | 0.180 |
Why?
|
Middle Aged | 37 | 2024 | 219560 | 0.170 |
Why?
|
Carotid Artery Injuries | 1 | 2000 | 96 | 0.170 |
Why?
|
Interleukin-23 Subunit p19 | 1 | 2019 | 23 | 0.170 |
Why?
|
Cats | 1 | 2021 | 975 | 0.170 |
Why?
|
Male | 48 | 2024 | 358742 | 0.170 |
Why?
|
Ceramides | 1 | 2000 | 200 | 0.160 |
Why?
|
Feces | 5 | 2018 | 1457 | 0.160 |
Why?
|
Klebsiella pneumoniae | 1 | 2021 | 254 | 0.160 |
Why?
|
Gallbladder | 2 | 2024 | 305 | 0.160 |
Why?
|
Immune Evasion | 1 | 2022 | 362 | 0.150 |
Why?
|
Nausea | 1 | 2021 | 677 | 0.150 |
Why?
|
Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2017 | 5 | 0.150 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20052 | 0.150 |
Why?
|
Pakistan | 3 | 2024 | 293 | 0.150 |
Why?
|
Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2017 | 23 | 0.150 |
Why?
|
Viral Load | 3 | 2022 | 3321 | 0.150 |
Why?
|
Diarrhea | 3 | 2023 | 1317 | 0.140 |
Why?
|
Receptors, IgG | 1 | 2020 | 559 | 0.140 |
Why?
|
Infant | 11 | 2023 | 36054 | 0.140 |
Why?
|
Fever | 2 | 2023 | 1617 | 0.140 |
Why?
|
Pandemics | 10 | 2023 | 8611 | 0.140 |
Why?
|
Bacteriological Techniques | 1 | 2018 | 279 | 0.140 |
Why?
|
Flagellin | 1 | 2017 | 124 | 0.140 |
Why?
|
Antigens, Viral | 1 | 2020 | 980 | 0.140 |
Why?
|
Escherichia coli | 2 | 2021 | 4215 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2019 | 414 | 0.140 |
Why?
|
Immunity, Innate | 2 | 2019 | 3046 | 0.130 |
Why?
|
Bayes Theorem | 3 | 2023 | 2322 | 0.130 |
Why?
|
Immunologic Tests | 1 | 2016 | 103 | 0.130 |
Why?
|
Travel | 1 | 2021 | 785 | 0.120 |
Why?
|
Cohort Studies | 9 | 2022 | 41252 | 0.120 |
Why?
|
General Practitioners | 1 | 2016 | 101 | 0.120 |
Why?
|
Bacterial Shedding | 1 | 2014 | 10 | 0.120 |
Why?
|
Plasma | 1 | 2018 | 584 | 0.120 |
Why?
|
Mice | 15 | 2024 | 81107 | 0.110 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2018 | 586 | 0.110 |
Why?
|
HIV Antibodies | 1 | 2020 | 1300 | 0.110 |
Why?
|
Bacterial Load | 1 | 2014 | 151 | 0.110 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2000 | 1730 | 0.110 |
Why?
|
Microspheres | 1 | 2016 | 787 | 0.110 |
Why?
|
Blood Bactericidal Activity | 4 | 2015 | 126 | 0.110 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2015 | 328 | 0.110 |
Why?
|
Biosensing Techniques | 2 | 2017 | 649 | 0.110 |
Why?
|
Animals | 17 | 2024 | 167777 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2716 | 0.110 |
Why?
|
RNA, Bacterial | 2 | 2011 | 385 | 0.110 |
Why?
|
Nucleic Acids | 1 | 2015 | 187 | 0.110 |
Why?
|
Blood | 2 | 2016 | 586 | 0.100 |
Why?
|
Nepal | 1 | 2013 | 301 | 0.100 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2015 | 489 | 0.100 |
Why?
|
Protein Array Analysis | 1 | 2013 | 401 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1585 | 0.100 |
Why?
|
T-Lymphocytes | 5 | 2021 | 10171 | 0.100 |
Why?
|
Hemolysin Proteins | 2 | 2024 | 114 | 0.100 |
Why?
|
Bacteriophages | 1 | 2014 | 372 | 0.090 |
Why?
|
Species Specificity | 3 | 2015 | 2417 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15785 | 0.090 |
Why?
|
Monocytes | 1 | 2019 | 2570 | 0.090 |
Why?
|
Virulence | 2 | 2014 | 1298 | 0.090 |
Why?
|
Gene Expression Profiling | 4 | 2018 | 9405 | 0.090 |
Why?
|
Oligosaccharides | 1 | 2012 | 403 | 0.090 |
Why?
|
Weight Loss | 1 | 2021 | 2671 | 0.080 |
Why?
|
Immunization, Secondary | 3 | 2021 | 368 | 0.080 |
Why?
|
Water Supply | 1 | 2010 | 206 | 0.080 |
Why?
|
Rabbits | 3 | 2023 | 4771 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2017 | 1401 | 0.080 |
Why?
|
Epidemics | 1 | 2014 | 512 | 0.080 |
Why?
|
Anti-Bacterial Agents | 3 | 2018 | 7403 | 0.080 |
Why?
|
Vaccines | 1 | 2016 | 832 | 0.070 |
Why?
|
RNA, Messenger | 4 | 2016 | 12760 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1897 | 0.070 |
Why?
|
Diagnostic Tests, Routine | 1 | 2013 | 787 | 0.070 |
Why?
|
Disease Models, Animal | 7 | 2023 | 18125 | 0.070 |
Why?
|
Bacterial Vaccines | 1 | 2009 | 401 | 0.070 |
Why?
|
Leptin | 1 | 2015 | 1591 | 0.070 |
Why?
|
Genes, Bacterial | 1 | 2010 | 1071 | 0.070 |
Why?
|
Asia | 2 | 2018 | 616 | 0.070 |
Why?
|
Fluid Therapy | 1 | 2010 | 578 | 0.070 |
Why?
|
Antitoxins | 2 | 2019 | 77 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3758 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4549 | 0.070 |
Why?
|
Epitopes | 2 | 2022 | 2502 | 0.060 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2018 | 238 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12951 | 0.060 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2379 | 0.060 |
Why?
|
Biosurveillance | 1 | 2024 | 16 | 0.060 |
Why?
|
Administration, Cutaneous | 2 | 2020 | 712 | 0.060 |
Why?
|
Genetic Variation | 2 | 2017 | 6548 | 0.060 |
Why?
|
Massachusetts | 3 | 2023 | 8823 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2012 | 1807 | 0.060 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6209 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2024 | 80170 | 0.060 |
Why?
|
Aged | 9 | 2024 | 168217 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13468 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2014 | 5490 | 0.050 |
Why?
|
Cells, Cultured | 3 | 2013 | 18942 | 0.050 |
Why?
|
Gallbladder Diseases | 1 | 2024 | 137 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2189 | 0.050 |
Why?
|
Enterotoxins | 2 | 2016 | 366 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3867 | 0.050 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 25953 | 0.050 |
Why?
|
Th17 Cells | 2 | 2022 | 785 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2020 | 2433 | 0.050 |
Why?
|
Evolution, Molecular | 2 | 2022 | 1885 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2014 | 4353 | 0.050 |
Why?
|
Peru | 1 | 2024 | 884 | 0.050 |
Why?
|
Family Characteristics | 2 | 2018 | 1000 | 0.050 |
Why?
|
Convalescence | 1 | 2021 | 106 | 0.050 |
Why?
|
France | 3 | 2016 | 499 | 0.050 |
Why?
|
Binding Sites, Antibody | 1 | 2021 | 337 | 0.050 |
Why?
|
Escape Reaction | 1 | 2000 | 57 | 0.050 |
Why?
|
Intubation | 1 | 2020 | 139 | 0.040 |
Why?
|
Territoriality | 1 | 1999 | 6 | 0.040 |
Why?
|
Plants, Medicinal | 1 | 2000 | 165 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 131 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2020 | 363 | 0.040 |
Why?
|
Limit of Detection | 1 | 2020 | 270 | 0.040 |
Why?
|
Genome, Bacterial | 2 | 2018 | 770 | 0.040 |
Why?
|
Diazepam | 1 | 2000 | 215 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2022 | 418 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22031 | 0.040 |
Why?
|
Exploratory Behavior | 1 | 2000 | 273 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 617 | 0.040 |
Why?
|
Immunization Schedule | 1 | 2020 | 223 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 900 | 0.040 |
Why?
|
Vocalization, Animal | 1 | 1999 | 93 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 4567 | 0.040 |
Why?
|
Hospitalization | 4 | 2021 | 10653 | 0.040 |
Why?
|
Avoidance Learning | 1 | 2000 | 248 | 0.040 |
Why?
|
Bacterial Toxins | 2 | 2016 | 931 | 0.040 |
Why?
|
Biotechnology | 1 | 2020 | 281 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 149 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 743 | 0.040 |
Why?
|
Tunica Intima | 1 | 2000 | 459 | 0.040 |
Why?
|
Anti-Anxiety Agents | 1 | 2000 | 397 | 0.040 |
Why?
|
Transgenes | 1 | 2021 | 1007 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 642 | 0.040 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2021 | 325 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20500 | 0.040 |
Why?
|
Polysaccharides, Bacterial | 1 | 2020 | 574 | 0.040 |
Why?
|
Glycosylation | 1 | 2020 | 1095 | 0.040 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2021 | 225 | 0.040 |
Why?
|
Escherichia coli Proteins | 2 | 2016 | 1065 | 0.040 |
Why?
|
Phylogeny | 2 | 2018 | 2774 | 0.040 |
Why?
|
Peptides | 1 | 2009 | 4341 | 0.040 |
Why?
|
Protein Subunits | 1 | 2020 | 942 | 0.040 |
Why?
|
Hyperplasia | 1 | 2000 | 1154 | 0.040 |
Why?
|
Plant Extracts | 1 | 2000 | 489 | 0.040 |
Why?
|
Gene Transfer, Horizontal | 1 | 2017 | 144 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2022 | 1974 | 0.040 |
Why?
|
Acute Disease | 2 | 2018 | 7225 | 0.040 |
Why?
|
Microbiological Techniques | 1 | 1977 | 98 | 0.030 |
Why?
|
Hybridomas | 1 | 2017 | 442 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15396 | 0.030 |
Why?
|
Dependovirus | 1 | 2021 | 711 | 0.030 |
Why?
|
Africa | 1 | 2018 | 705 | 0.030 |
Why?
|
North America | 1 | 2019 | 1276 | 0.030 |
Why?
|
Oxides | 1 | 2017 | 401 | 0.030 |
Why?
|
Age Factors | 3 | 2021 | 18357 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14481 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 268 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 621 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1245 | 0.030 |
Why?
|
Fluorescence Polarization | 1 | 2015 | 140 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58681 | 0.030 |
Why?
|
Polysaccharides | 1 | 2022 | 1007 | 0.030 |
Why?
|
Public Health | 2 | 2023 | 2658 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2316 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 998 | 0.030 |
Why?
|
Fungi | 1 | 1977 | 339 | 0.030 |
Why?
|
Duodenum | 1 | 2018 | 485 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23341 | 0.030 |
Why?
|
Stress, Psychological | 2 | 2000 | 4457 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 933 | 0.030 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 84 | 0.030 |
Why?
|
Mutation | 3 | 2022 | 29915 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10112 | 0.030 |
Why?
|
Adhesins, Bacterial | 1 | 2014 | 118 | 0.030 |
Why?
|
Social Behavior | 1 | 2000 | 1132 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2000 | 1486 | 0.030 |
Why?
|
Models, Biological | 2 | 2009 | 9461 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3298 | 0.030 |
Why?
|
Microbial Viability | 1 | 2015 | 238 | 0.030 |
Why?
|
Zinc | 1 | 2017 | 687 | 0.030 |
Why?
|
Language | 1 | 2023 | 1532 | 0.030 |
Why?
|
Prophages | 1 | 2013 | 38 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 432 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2000 | 853 | 0.030 |
Why?
|
Hot Temperature | 1 | 2019 | 1434 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2275 | 0.030 |
Why?
|
Point Mutation | 1 | 2017 | 1593 | 0.030 |
Why?
|
Antibodies | 1 | 2020 | 2420 | 0.030 |
Why?
|
History, 21st Century | 1 | 2018 | 1573 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2024 | 26182 | 0.030 |
Why?
|
Time Factors | 3 | 2020 | 39873 | 0.030 |
Why?
|
Haplotypes | 1 | 2018 | 2764 | 0.030 |
Why?
|
Genomics | 2 | 2018 | 5789 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2012 | 328 | 0.020 |
Why?
|
Cell Separation | 1 | 2017 | 1720 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5410 | 0.020 |
Why?
|
Immunization | 1 | 2015 | 1227 | 0.020 |
Why?
|
Rehydration Solutions | 1 | 2010 | 43 | 0.020 |
Why?
|
Erythromycin | 1 | 2010 | 117 | 0.020 |
Why?
|
Vaccines, Attenuated | 1 | 2012 | 314 | 0.020 |
Why?
|
History, 20th Century | 1 | 2018 | 2772 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 677 | 0.020 |
Why?
|
Caribbean Region | 1 | 2010 | 191 | 0.020 |
Why?
|
History, 18th Century | 1 | 2010 | 207 | 0.020 |
Why?
|
Serotyping | 1 | 2010 | 324 | 0.020 |
Why?
|
Tetracycline | 1 | 2010 | 219 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5199 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9312 | 0.020 |
Why?
|
Latin America | 1 | 2010 | 405 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8554 | 0.020 |
Why?
|
Mice, Inbred DBA | 2 | 2000 | 622 | 0.020 |
Why?
|
Iron | 1 | 2017 | 1786 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11894 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3765 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2014 | 2673 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 2569 | 0.020 |
Why?
|
Doxycycline | 1 | 2010 | 341 | 0.020 |
Why?
|
Biological Evolution | 1 | 2014 | 1074 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2882 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22006 | 0.020 |
Why?
|
HIV Infections | 1 | 2015 | 17275 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9304 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 746 | 0.020 |
Why?
|
Malnutrition | 1 | 2014 | 639 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2015 | 10417 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 1991 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3732 | 0.020 |
Why?
|
Th1 Cells | 1 | 2012 | 1031 | 0.020 |
Why?
|
Th2 Cells | 1 | 2012 | 1047 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3888 | 0.020 |
Why?
|
Bacteria | 1 | 1977 | 2199 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 1038 | 0.020 |
Why?
|
Incidence | 2 | 2022 | 21273 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10495 | 0.020 |
Why?
|
Mammography | 1 | 1997 | 2427 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6768 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2210 | 0.020 |
Why?
|
World Health Organization | 1 | 2010 | 1312 | 0.010 |
Why?
|
Base Sequence | 1 | 2015 | 12436 | 0.010 |
Why?
|
Apoptosis | 1 | 2000 | 9468 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6520 | 0.010 |
Why?
|
Mass Screening | 2 | 1997 | 5425 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12262 | 0.010 |
Why?
|
United States | 2 | 2024 | 72140 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3023 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3774 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4839 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5484 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2010 | 4624 | 0.010 |
Why?
|
Risk Factors | 2 | 2022 | 73806 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12096 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29558 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2010 | 4711 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 1997 | 21017 | 0.010 |
Why?
|
Ultrasonics | 1 | 1999 | 206 | 0.010 |
Why?
|
Urination | 1 | 1999 | 202 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2000 | 15638 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9575 | 0.010 |
Why?
|
Culture Media | 1 | 1977 | 899 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1977 | 1628 | 0.010 |
Why?
|
Aggression | 1 | 1999 | 746 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12096 | 0.010 |
Why?
|
Social Environment | 1 | 1999 | 1022 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64379 | 0.010 |
Why?
|
Liver | 1 | 1989 | 7502 | 0.010 |
Why?
|
Cross-Cultural Comparison | 1 | 1997 | 635 | 0.010 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 1989 | 72 | 0.010 |
Why?
|
Program Evaluation | 1 | 1996 | 2490 | 0.000 |
Why?
|
Data Collection | 1 | 1997 | 3322 | 0.000 |
Why?
|
Quality Assurance, Health Care | 1 | 1997 | 2167 | 0.000 |
Why?
|
Anxiety | 1 | 2000 | 4538 | 0.000 |
Why?
|
Models, Anatomic | 1 | 1989 | 681 | 0.000 |
Why?
|
Tissue Distribution | 1 | 1989 | 2263 | 0.000 |
Why?
|
Staining and Labeling | 1 | 1989 | 1083 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1997 | 3586 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1989 | 11070 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1989 | 8946 | 0.000 |
Why?
|